ANRO Alto Neuroscience, Inc. Common Stock
NYSE · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 12, 2026
$24,80
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$5,23mínimo 52 semanas
$37,48máximo 52 semanas
Capitalización Bursátil (MRQ)
$870M
P/E
-12.4
BPA
$-2.19
tus insignias
Rango 52S
$5–$37
Calificación del Analista
STRONG BUY
Precio Objetivo
$38
P/E
-12.4
ROE
-46.1%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ANRO Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$24.80
Capitalización Bursátil (MRQ)
$870M
P/E
-12.4
BPA
$-2.19
ROE
-46.1%
Deuda/Capital (MRQ)
0.1
Rango 52S
$5–$37
ANRO Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-2.192023-12-31 → 2025-12-31
Flujo de caja libre$-52M2024-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ANRO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -12.4 | · | · | · | |
| P/C (MRQ) | 4.0 | · | · | · | |
| EV / EBITDA | -10.7 | · | · | · | |
| Precio / FCF (TTM) | -12.6 | · | · | · | |
| Precio / Flujo de Caja (TTM) | -12.7 | · | · | · | |
| EV / FCF | -13.7 | · | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 5.8 | · | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ANRO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -34.9% | · | · | · | |
| ROE | -46.1% | · | · | · |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ANRO | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.1 | · | · | · | |
| Ratio corriente (MRQ) | 14.9 | · | · | · | |
| Quick Ratio (Ratio Rápido) | 15.6 | · | · | · | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.1 | · | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-1.8%
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | $-0.65 | $-0.75 | 13.2% | |
| 31 de marzo de 2026 | $-0.80 | $-0.55 | -46.2% | |
| 31 de diciembre de 2025 | $-0.58 | $-0.54 | -7.1% | |
| 30 de septiembre de 2025 | $-0.52 | $-0.68 | 23.7% | |
| 30 de junio de 2025 | $-0.65 | $-0.63 | -4.0% | |
| 31 de marzo de 2025 | $-0.56 | $-0.62 | 9.7% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $46M | $47M | $30M | |
| SG&A Expense | $21M | $22M | $8M | |
| Operating Expenses | $66M | $69M | $38M | |
| Operating Income | $-66M | $-69M | $-38M | |
| Interest Income | $7M | $9M | $2M | |
| Other Non-op | $3M | $7M | $2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-63M | $-61M | $-36M | |
| EPS (Basic) | $-2.19 | $-2.50 | $-9.73 | |
| EPS (Diluted) | $-2.19 | $-2.50 | $-9.73 | |
| Shares (Basic) | 28,852,000 | 24,602,000 | 3,731,000 | |
| Shares (Diluted) | 28,852,000 | 24,602,000 | 3,731,000 | |
| EBITDA | $-66M | $-68M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $176M | $168M | $83M | |
| Prepaid Expense | $1M | $1M | $3M | |
| Other Current Assets | · | $30.0K | $112.0K | |
| Current Assets | $178M | $169M | $85M | |
| PP&E (Net) | $2M | $3M | $1M | |
| Accum. Depreciation | $2M | $1M | $684.0K | |
| Total Assets | $185M | $178M | $87M | |
| Accounts Payable | $2M | $2M | $1M | |
| Accrued Liabilities | $9M | $8M | $5M | |
| Current Liabilities | $11M | $10M | $6M | |
| Capital Leases | $4M | $5M | $0 | |
| Total Liabilities | $34M | $26M | $17M | |
| Long-term Debt | $17M | $10M | $10M | |
| Total Debt | $17M | $10M | · | |
| Paid-in Capital | $353M | $290M | $5M | |
| Retained Earnings | $-202M | $-138M | $-77M | |
| AOCI | $22.0K | $-101.0K | $-79.0K | |
| Stockholders' Equity | $151M | $151M | $-72M | |
| Liabilities + Equity | $185M | $178M | $87M | |
| Shares Outstanding | 31,924,000 | 26,987,000 | 3,832,000 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | · | $502.0K | $373.0K | |
| Stock-based Comp | $8M | $8M | $3M | |
| Other Non-cash | · | $6M | · | |
| Operating Cash Flow | $-52M | $-47M | $-33M | |
| CapEx | $24.0K | $2M | $470.0K | |
| Investing Cash Flow | $-24.0K | $-2M | $-470.0K | |
| Net Debt Issued | $-10M | · | · | |
| Financing Cash Flow | $60M | $136M | $68M | |
| Net Change in Cash | $8M | $86M | $34M | |
| Free Cash Flow | $-52M | $-49M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -34.9% | -46.5% | · | |
| ROE | -46.1% | -38.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.7 | 16.9 | · | |
| Quick Ratio | 15.6 | 16.8 | · | |
| Debt / Equity | 0.1 | 0.1 | · | |
| LT Debt / Equity | 0.1 | 0.1 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $4.73 | $5.61 | · | |
| Cash Flow / Share | $-1.79 | $-1.93 | · | |
| Cash / Share | $5.53 | $6.23 | · | |
| EPS (TTM) | $-2.19 | $-2.50 | $-9.73 |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-63M | $-61M | $-36M | |
| Market Cap | $568M | $114M | · | |
| Enterprise Value | $409M | $-44M | · | |
| P/E | -8.1 | -1.7 | · | |
| P/B | 3.8 | 0.8 | · | |
| P / Tangible Book | 3.8 | 0.8 | · | |
| P / Cash Flow | -11.0 | -2.4 | · | |
| P / FCF | -11.0 | -2.3 | · | |
| EV / EBITDA | -6.2 | 0.6 | · | |
| EV / FCF | -7.9 | 0.9 | · | |
| Earnings Yield | -12.3% | -59.1% | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $22M | $20M | $12M | $11M | $13M | $10M | $11M | $13M | $13M | $10M | $10M | $8M | $7M | $6M | |
| SG&A Expense | $7M | $7M | $5M | $4M | $6M | $6M | $6M | $6M | $5M | $4M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $29M | $27M | $17M | $15M | $19M | $16M | $17M | $19M | $18M | $14M | $12M | $10M | $9M | $7M | |
| Operating Income | $-29M | $-27M | $-17M | $-15M | $-19M | $-16M | $-17M | $-19M | $-18M | $-14M | $-12M | $-10M | $-9M | $-7M | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $738.0K | $714.0K | $667.0K | $230.0K | |
| Other Non-op | $1M | $901.0K | $873.0K | $770.0K | $976.0K | $507.0K | $2M | $2M | $2M | $969.0K | $548.0K | $577.0K | $462.0K | $-83.0K | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-28M | $-26M | $-16M | $-14M | $-18M | $-15M | $-15M | $-17M | $-16M | $-13M | $-11M | $-9M | $-9M | $-7M | |
| EPS (Basic) | $-0.65 | $-0.80 | $-0.46 | $-0.52 | $-0.65 | $-0.56 | $-0.52 | $-0.62 | $-0.60 | $-0.76 | $-2.99 | $-2.44 | $-2.33 | $-1.97 | |
| EPS (Diluted) | $-0.65 | $-0.80 | $-0.46 | $-0.52 | $-0.65 | $-0.56 | $-0.52 | $-0.62 | $-0.60 | $-0.76 | $-2.99 | $-2.44 | $-2.33 | $-1.97 | |
| Shares (Basic) | 42,813,000 | 32,893,000 | · | 27,104,000 | 27,072,000 | 27,049,000 | · | 26,959,000 | 26,913,000 | 17,600,000 | · | 3,742,000 | 3,716,000 | 3,691,000 | |
| Shares (Diluted) | 42,813,000 | 32,893,000 | · | 27,104,000 | 27,072,000 | 27,049,000 | · | 26,959,000 | 26,913,000 | 17,600,000 | · | 3,742,000 | 3,716,000 | 3,691,000 | |
| EBITDA | $-29M | $-27M | · | $-15M | $-19M | $-16M | · | $-19M | $-18M | $-14M | · | · | · | · |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $244M | $264M | $176M | $138M | $148M | $161M | $168M | $182M | $193M | $206M | $83M | · | · | · | |
| Prepaid Expense | $4M | $5M | $1M | $2M | $2M | $3M | $1M | $2M | $2M | $2M | $3M | · | · | · | |
| Other Current Assets | · | · | · | · | · | $23.0K | · | $277.0K | $148.0K | $150.0K | $112.0K | · | · | · | |
| Current Assets | $247M | $269M | $178M | $139M | $150M | $164M | $169M | $184M | $195M | $208M | $85M | · | · | · | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $1M | · | · | · | |
| Accum. Depreciation | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $909.0K | $791.0K | $781.0K | $684.0K | · | · | · | |
| Total Assets | $254M | $276M | $185M | $147M | $158M | $172M | $178M | $192M | $197M | $210M | $87M | · | · | · | |
| Accounts Payable | $4M | $3M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $1M | · | · | · | |
| Accrued Liabilities | $9M | $8M | $9M | $7M | $6M | $6M | $8M | $8M | $6M | $4M | $5M | · | · | · | |
| Current Liabilities | $17M | $13M | $11M | $9M | $8M | $7M | $10M | $14M | $10M | $8M | $6M | · | · | · | |
| Capital Leases | $3M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | · | · | $0 | · | · | · | |
| Total Liabilities | $35M | $33M | $34M | $35M | $34M | $33M | $26M | $27M | $18M | $17M | $17M | · | · | · | |
| Long-term Debt | $16M | $16M | $17M | · | · | · | $10M | $10M | $10M | $10M | · | · | · | · | |
| Total Debt | $16M | $16M | · | $20M | $20M | $20M | · | $10M | $10M | $10M | · | · | · | · | |
| Paid-in Capital | $475M | $471M | $353M | $297M | $295M | $293M | $290M | $288M | $286M | $284M | $5M | · | · | · | |
| Retained Earnings | $-256M | $-228M | $-202M | $-185M | $-171M | $-154M | $-138M | $-123M | $-106M | $-90M | $-77M | · | · | · | |
| AOCI | $17.0K | $13.0K | $22.0K | $14.0K | $31.0K | $14.0K | $-101.0K | $-95.0K | $-89.0K | $-84.0K | $-79.0K | · | · | · | |
| Stockholders' Equity | $219M | $243M | $151M | $112M | $123M | $139M | $151M | $165M | $180M | $193M | $-72M | · | · | · | |
| Liabilities + Equity | $254M | $276M | $185M | $147M | $158M | $172M | $178M | $192M | $197M | $210M | $87M | · | · | · | |
| Shares Outstanding | 35,094,000 | 35,053,000 | 31,924,000 | 27,168,000 | 27,072,000 | 27,072,000 | 26,987,000 | 26,968,000 | 26,951,000 | 26,884,000 | 3,832,000 | · | · | · |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $100.0K | $171.0K | · | $200.0K | $100.0K | $97.0K | $87.0K | $100.0K | $100.0K | $86.0K | |
| Stock-based Comp | $4M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $606.0K | $541.0K | $1M | $484.0K | |
| Other Non-cash | · | · | · | · | · | $-4M | · | · | · | $158.0K | · | · | · | · | |
| Operating Cash Flow | $-20M | $-27M | $-12M | $-10M | $-14M | $-17M | $-13M | $-12M | $-12M | $-11M | $-12M | $-8M | $-7M | $-8M | |
| CapEx | $0 | $556.0K | $0 | $0 | $0 | $24.0K | $506.0K | $1M | $340.0K | $224.0K | $352.0K | $43.0K | $54.0K | $21.0K | |
| Investing Cash Flow | $0 | $-556.0K | $0 | $0 | $0 | $-24.0K | $-506.0K | $-1M | $-340.0K | $-224.0K | $-352.0K | $-43.0K | $-54.0K | $-21.0K | |
| Debt Issued | · | · | · | · | · | $20M | · | · | · | $0 | · | · | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $9M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-273.0K | $115M | $50M | $153.0K | $613.0K | $9M | $49.0K | $1M | $-234.0K | $135M | $43M | $49.0K | $-51.0K | $25M | |
| Net Change in Cash | $-20M | $87M | $39M | $-10M | $-13M | $-7M | $-13M | $-11M | $-12M | $123M | $31M | $-8M | $-7M | $17M | |
| Free Cash Flow | · | $-28M | · | · | · | $-17M | · | · | · | $-11M | · | · | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -13.4% | -11.7% | · | -8.4% | -10.0% | -8.0% | · | -17.5% | -16.2% | -12.8% | · | · | · | · | |
| ROE | -16.1% | -13.7% | · | -10.2% | -11.7% | -9.1% | · | -20.3% | -17.8% | -13.9% | · | · | · | · |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.9 | 20.5 | · | 15.4 | 18.4 | 22.5 | · | 13.1 | 19.9 | 26.0 | · | · | · | · | |
| Quick Ratio | 14.6 | 20.1 | · | 15.2 | 18.2 | 22.2 | · | 13.0 | 19.6 | 25.7 | · | · | · | · | |
| Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.25 | $6.94 | · | $4.11 | $4.56 | $5.14 | · | $6.12 | $6.67 | $7.18 | · | · | · | · | |
| Cash Flow / Share | · | $-0.82 | · | · | · | $-0.61 | · | · | · | $-0.62 | · | · | · | · | |
| Cash / Share | $6.95 | $7.52 | · | $5.07 | $5.45 | $5.94 | · | $6.74 | $7.17 | $7.66 | · | · | · | · | |
| EPS (TTM) | $-2.43 | $-2.43 | · | $-2.25 | $-2.35 | $-2.30 | · | $-4.97 | $-6.79 | $-8.52 | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-84M | $-74M | · | $-62M | $-65M | $-63M | · | $-57M | $-50M | $-42M | · | · | · | · | |
| Market Cap | $926M | $788M | · | $109M | $60M | $58M | · | $309M | $288M | $413M | · | · | · | · | |
| Enterprise Value | $699M | $540M | · | $-8M | $-68M | $-82M | · | $137M | $105M | $217M | · | · | · | · | |
| P/E | -10.9 | -9.3 | · | -1.8 | -0.9 | -0.9 | · | -2.3 | -1.6 | -1.8 | · | · | · | · | |
| P/B | 4.2 | 3.2 | · | 1.0 | 0.5 | 0.4 | · | 1.9 | 1.6 | 2.1 | · | · | · | · | |
| P / Tangible Book | 4.2 | 3.2 | · | 1.0 | 0.5 | 0.4 | · | 1.9 | 1.6 | 2.1 | · | · | · | · | |
| P / Cash Flow | · | -29.1 | · | · | · | -3.5 | · | · | · | -37.6 | · | · | · | · | |
| Earnings Yield | -9.2% | -10.8% | · | -56.0% | -106.8% | -106.5% | · | -43.4% | -63.5% | -55.5% | · | · | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Beneficio neto | $-63M | $-61M | $-36M |
| EPS Diluido | $-2.19 | $-2.50 | $-9.73 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Deuda / Patrimonio | 0.1 | 0.1 | · |
| Ratio corriente | 15.7 | 16.9 | · |
| Ratio Rápido | 15.6 | 16.8 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Flujo de caja libre | $-52M | $-49M | · |
Propietarios institucionales (13F) 123 declarantes · $796.9M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
123
Valor en tenencia
$796.9M
Nuevas posiciones
28
Posiciones cerradas
21
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 28 (+2 vs trimestre anterior) | 21 (+15 vs trimestre anterior) | 39 (+9 vs trimestre anterior) | 31 (-11 vs trimestre anterior) | +2.3M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Alpha Wave Global, LP | $97 847 707 | 3 707 757 | 12,28% | Acciones |
| Commodore Capital LP | $71 865 142 | 2 723 196 | 9,02% | Acciones |
| BlackRock, Inc. | $55 973 428 | 2 121 009 | 7,02% | Acciones |
| PERCEPTIVE ADVISORS LLC | $42 485 076 | 1 609 893 | 5,33% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42 224 000 | 1 600 000 | 5,30% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $36 668 298 | 1 389 477 | 4,60% | Acciones |
| Spruce Street Capital LP | $35 706 910 | 1 353 047 | 4,48% | Acciones |
| Vivo Capital, LLC | $31 901 763 | 1 208 858 | 4,00% | Acciones |
| FRANKLIN RESOURCES INC | $26 741 172 | 1 013 307 | 3,36% | Acciones |
| VANGUARD GROUP INC | $24 312 077 | 1 365 847 | 3,05% | Acciones |
| ARMISTICE CAPITAL, LLC | $22 800 960 | 864 000 | 2,86% | Acciones |
| Affinity Asset Advisors, LLC | $22 431 500 | 850 000 | 2,81% | Acciones |
| Vestal Point Capital, LP | $20 716 150 | 785 000 | 2,60% | Acciones |
| STATE STREET CORP | $18 102 089 | 685 945 | 2,27% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $17 902 152 | 678 199 | 2,25% | Acciones |
| 72 Investment Holdings, LLC | $17 622 661 | 667 778 | 2,21% | Acciones |
| NORTHERN TRUST CORP | $16 696 980 | 632 701 | 2,10% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $14 734 065 | 558 320 | 1,85% | Acciones |
| Point72 Asset Management, L.P. | $13 272 851 | 502 950 | 1,67% | Acciones |
| Integral Health Asset Management, LLC | $13 195 000 | 500 000 | 1,66% | Acciones |
| Venrock Adviser, LLC | $13 195 000 | 500 000 | 1,66% | Acciones |
| Driehaus Capital Management LLC | $12 867 131 | 487 576 | 1,61% | Acciones |
| Parkman Healthcare Partners LLC | $11 322 234 | 429 035 | 1,42% | Acciones |
| Ikarian Capital, LLC | $10 749 651 | 407 338 | 1,35% | Acciones |
| ORBIMED ADVISORS LLC | $6 804 714 | 257 852 | 0,85% | Acciones |
| Schonfeld Strategic Advisors LLC | $6 798 881 | 257 631 | 0,85% | Acciones |
| GOLDMAN SACHS GROUP INC | $6 249 944 | 236 830 | 0,78% | Acciones |
| MARSHALL WACE, LLP | $5 951 025 | 225 503 | 0,75% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $5 575 072 | 211 257 | 0,70% | Acciones |
| AMERIPRISE FINANCIAL INC | $5 040 385 | 190 996 | 0,63% | Acciones |
| Saturn V Capital Management LP | $4 824 857 | 182 829 | 0,61% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4 779 255 | 181 101 | 0,60% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $3 887 221 | 147 299 | 0,49% | Acciones |
| Eversept Partners, LP | $3 385 468 | 128 286 | 0,42% | Acciones |
| TWO SIGMA ADVISERS, LP | $2 849 780 | 160 100 | 0,36% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $2 803 515 | 106 234 | 0,35% | Acciones |
| ALKEON CAPITAL MANAGEMENT LLC | $2 694 445 | 102 101 | 0,34% | Acciones |
| STIFEL FINANCIAL CORP | $2 255 827 | 85 480 | 0,28% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2 126 585 | 80 583 | 0,27% | Acciones |
| AWM Investment Company, Inc. | $2 111 200 | 80 000 | 0,26% | Acciones |
| Bank of New York Mellon Corp | $2 014 348 | 76 330 | 0,25% | Acciones |
| MORGAN STANLEY | $1 977 666 | 74 940 | 0,25% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 884 220 | 71 399 | 0,24% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 871 393 | 70 913 | 0,23% | Acciones |
| AdvisorShares Investments LLC | $1 867 040 | 70 748 | 0,23% | Acciones |
| Nuveen, LLC | $1 645 205 | 62 342 | 0,21% | Acciones |
| UBS Group AG | $1 549 014 | 58 697 | 0,19% | Acciones |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 336 733 | 50 653 | 0,17% | Acciones |
| XTX Topco Ltd | $1 229 800 | 46 601 | 0,15% | Acciones |
| TD Asset Management Inc | $1 155 882 | 43 800 | 0,15% | Acciones |
Informantes de la empresa 12 insiders · 4 directivos · 9 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Amit Etkin | PRESIDENT AND CEO | 14 de mayo de 2026 G | 833 949 | 0 | 0 | $0 |
| Nicholas Conrad Smith | PRESIDENT AND CFO | 30 de septiembre de 2026 M | 24 060 | 0 | 3 | $-3 566 991 |
| Jr. Michael Conick Hanley | CHIEF OPERATING OFFICER | 11 de febrero de 2026 A | · | 0 | 0 | $0 |
| Adam Savitz | CHIEF MEDICAL OFFICER | 11 de febrero de 2026 A | 39 851 | 0 | 0 | $0 |
| Andrew Craig Miller | Consejero | 27 de mayo de 2026 A | · | 0 | 0 | $0 |
| Husseini Manji | Consejero | 12 de mayo de 2026 A | · | 0 | 0 | $0 |
| Gwill York | Consejero | 12 de mayo de 2026 A | 23 917 | 0 | 0 | $0 |
| Christopher Nixon Cox | Consejero | 12 de mayo de 2026 A | 715 653 | 0 | 0 | $0 |
| Ramiro Sanchez | Consejero | 12 de mayo de 2026 A | · | 0 | 0 | $0 |
| Andrew Dreyfus | Consejero | 12 de mayo de 2026 A | · | 0 | 0 | $0 |
| Maha Radhakrishnan | Consejero | 8 de marzo de 2024 A | · | 0 | 0 | $0 |
| Po Yu (Jeff) Chen | Consejero | 6 de febrero de 2024 C | 47 709 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 22 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| DWAS · Invesco Exchange-Traded Fund Trust … | 1,38% | 221 017 SH | 2 de octubre de 2026 | Diario |
| IBRN · iShares Trust | 1,04% | 2 461 SH | 11 de septiembre de 2026 | Diario |
| PTH · Invesco Exchange-Traded Fund Trust | 1,04% | 118 475 SH | 2 de octubre de 2026 | Diario |
| PILL · Direxion Shares ETF Trust | 0,90% | 6 833 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,84% | 14 476 NS | 31 de julio de 2026 | N-PORT |
| IWC · iShares Trust | 0,20% | 88 973 SH | 11 de septiembre de 2026 | Diario |
| IBB · iShares Trust | 0,08% | 269 543 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,05% | 244 377 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 28 057 SH | 19 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,03% | 671 421 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,02% | 12 479 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 150 871 SH | 19 de agosto de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 346 522 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,01% | 1 512 SH | 11 de septiembre de 2026 | Diario |
| DCOR · Dimensional ETF Trust | 0,00% | 1 813 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 37 712 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 7 724 SH | 11 de septiembre de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 2 765 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 1 273 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 011 881 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 173 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 1 473 SH | 11 de septiembre de 2026 | Diario |
ANRO Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 17 analistas
COMPRA
Objetivo mediano
$37.00
+49,2%
9 52,9%
Compra fuerte
6 35,3%
Compra
2 11,8%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
10 analistas · 2026-10-02Objetivo medio $38.38 +54,8%
← Por Debajo de Todos los Objetivos
Precio Actual $24.80
Mín$26.00
Media$38.38
Máx$55.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ANRO | $568M | -8.1 | · | · | -46.1% | · |
| YARW | · | · | · | · | · | · |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| PCRX | $1.06B | 161.8 | 3.6% | 0.97% | 0.97% | · |
| SPTX | · | · | · | · | · | · |
| ALMS | · | -3.4 | · | -1011.8% | -61.9% | · |
| APMD | · | · | · | · | · | · |
| SGP | · | · | · | · | 50.0% | · |
| LXRX | $421M | -8.2 | 60.2% | -101.1% | -39.7% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 12, 2026